145 related articles for article (PubMed ID: 8537118)
1. The function of the octamer-binding site in the DRA promoter.
Voliva CF; Jabrane-Ferrat N; Peterlin BM
Immunogenetics; 1996; 43(1-2):20-6. PubMed ID: 8537118
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of cis-linked regulatory sequences in the HLA DRA promoter by transcription in vitro.
Hume CR; Lee JS
Tissue Antigens; 1990 Sep; 36(3):108-15. PubMed ID: 2278044
[TBL] [Abstract][Full Text] [Related]
3. In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma.
Wright KL; Ting JP
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7601-5. PubMed ID: 1502171
[TBL] [Abstract][Full Text] [Related]
4. Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression.
Abdulkadir SA; Krishna S; Thanos D; Maniatis T; Strominger JL; Ono SJ
J Exp Med; 1995 Aug; 182(2):487-500. PubMed ID: 7629508
[TBL] [Abstract][Full Text] [Related]
5. Unique TATA-binding protein-containing complexes and cofactors involved in transcription by RNA polymerases II and III.
Chiang CM; Ge H; Wang Z; Hoffmann A; Roeder RG
EMBO J; 1993 Jul; 12(7):2749-62. PubMed ID: 7687540
[TBL] [Abstract][Full Text] [Related]
6. Mapping of the interaction site of the defective transcription factor in the class II major histocompatibility complex mutant cell line clone-13 to the divergent X2-box.
Ono SJ; Song Z
J Biol Chem; 1995 Mar; 270(11):6396-402. PubMed ID: 7890777
[TBL] [Abstract][Full Text] [Related]
7. High mobility group I/Y protein functions as a specific cofactor for Oct-2A: mapping of interaction domains.
Abdulkadir SA; Casolaro V; Tai AK; Thanos D; Ono SJ
J Leukoc Biol; 1998 Nov; 64(5):681-91. PubMed ID: 9823775
[TBL] [Abstract][Full Text] [Related]
8. Core promoter-specific function of a mutant transcription factor TFIID defective in TATA-box binding.
Martinez E; Zhou Q; L'Etoile ND; Oelgeschläger T; Berk AJ; Roeder RG
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11864-8. PubMed ID: 8524864
[TBL] [Abstract][Full Text] [Related]
9. The transcriptional regulatory protein, YB-1, promotes single-stranded regions in the DRA promoter.
MacDonald GH; Itoh-Lindstrom Y; Ting JP
J Biol Chem; 1995 Feb; 270(8):3527-33. PubMed ID: 7876087
[TBL] [Abstract][Full Text] [Related]
10. Functional binding of the "TATA" box binding component of transcription factor TFIID to the -30 region of TATA-less promoters.
Wiley SR; Kraus RJ; Mertz JE
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5814-8. PubMed ID: 1321424
[TBL] [Abstract][Full Text] [Related]
11. Role of the X2 box in activated transcription from the DRA promoter in B cells.
Setterblad N; Peterlin BM; Andersson G
Immunogenetics; 1997; 46(4):318-25. PubMed ID: 9218534
[TBL] [Abstract][Full Text] [Related]
12. Drosophila TFIID binds to a conserved downstream basal promoter element that is present in many TATA-box-deficient promoters.
Burke TW; Kadonaga JT
Genes Dev; 1996 Mar; 10(6):711-24. PubMed ID: 8598298
[TBL] [Abstract][Full Text] [Related]
13. The regulatory gene, hXBP-1, and its target, HLA-DRA, utilize both common and distinct regulatory elements and protein complexes.
Ponath PD; Fass D; Liou HC; Glimcher LH; Strominger JL
J Biol Chem; 1993 Aug; 268(23):17074-82. PubMed ID: 8349596
[TBL] [Abstract][Full Text] [Related]
14. The major histocompatibility complex (MHC) Ea promoter: sequences and factors at the initiation site.
Mantovani R; Tora L; Moncollin V; Egly JM; Benoist C; Mathis D
Nucleic Acids Res; 1993 Oct; 21(21):4873-8. PubMed ID: 8177733
[TBL] [Abstract][Full Text] [Related]
15. Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters.
Hasegawa SL; Boss JM
Nucleic Acids Res; 1991 Nov; 19(22):6269-76. PubMed ID: 1956787
[TBL] [Abstract][Full Text] [Related]
16. Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions.
Jabrane-Ferrat N; Fontes JD; Boss JM; Peterlin BM
Mol Cell Biol; 1996 Sep; 16(9):4683-90. PubMed ID: 8756625
[TBL] [Abstract][Full Text] [Related]
17. Oct-1 maintains an intermediate, stable state of HLA-DRA promoter repression in Rb-defective cells: an Oct-1-containing repressosome that prevents NF-Y binding to the HLA-DRA promoter.
Osborne AR; Zhang H; Fejer G; Palubin KM; Niesen MI; Blanck G
J Biol Chem; 2004 Jul; 279(28):28911-9. PubMed ID: 15105429
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine A inhibits the activity of a TATA box-binding protein that is required for transcription from the adenovirus major late promoter.
Mahajan PB; Thompson EA
J Biol Chem; 1993 Aug; 268(22):16693-8. PubMed ID: 8344948
[TBL] [Abstract][Full Text] [Related]
19. Holo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter.
Zhou Q; Lieberman PM; Boyer TG; Berk AJ
Genes Dev; 1992 Oct; 6(10):1964-74. PubMed ID: 1398073
[TBL] [Abstract][Full Text] [Related]
20. CIF, an essential cofactor for TFIID-dependent initiator function.
Kaufmann J; Verrijzer CP; Shao J; Smale ST
Genes Dev; 1996 Apr; 10(7):873-86. PubMed ID: 8846923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
